DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR TAXOTERE

« Back to Dashboard

Clinical Trials for Taxotere

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00002662	Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer	Completed	Aventis Pharmaceuticals	Phase 3	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether paclitaxel is more effective than docetaxel for breast cancer. PURPOSE: Randomized phase III trial to study the effectiveness of paclitaxel or docetaxel in treating women with stage IIIB or metastatic breast cancer.
NCT00002707	Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed	Completed	National Cancer Institute (NCI)	Phase 3	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if chemotherapy given before surgery is more effective with or without docetaxel given before or after surgery for breast cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of chemotherapy using doxorubicin and cyclophosphamide with or without docetaxel in treating women who have stage II or stage III breast cancer.
NCT00002707	Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed	Completed	NSABP Foundation Inc	Phase 3	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if chemotherapy given before surgery is more effective with or without docetaxel given before or after surgery for breast cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of chemotherapy using doxorubicin and cyclophosphamide with or without docetaxel in treating women who have stage II or stage III breast cancer.
NCT00002775	Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer	Unknown status	Herbert Irving Comprehensive Cancer Center	Phase 1/Phase 2	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of combining docetaxel and estramustine in treating patients who have metastatic prostate cancer.
NCT00002825	Docetaxel in Treating Children With Recurrent Solid Tumors	Completed	National Cancer Institute (NCI)	Phase 2	Phase II trial to study the effectiveness of docetaxel in treating children with recurrent solid tumors. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

Clinical Trial Conditions for Taxotere

Condition Name

Condition Name for Taxotere
Intervention	Trials
Breast Cancer	62
Prostate Cancer	54
Lung Cancer	20
Non-Small Cell Lung Cancer	16

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Taxotere
Intervention	Trials
Breast Neoplasms	88
Prostatic Neoplasms	75
Carcinoma, Non-Small-Cell Lung	60
Lung Neoplasms	51

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Taxotere

Trials by Country

Trials by Country for Taxotere
Location	Trials
United States	978
Canada	99
Italy	50
Japan	32
France	31

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Taxotere
Location	Trials
California	55
Texas	53
New York	44
Florida	38
Illinois	37

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Taxotere

Clinical Trial Phase

Clinical Trial Phase for Taxotere
Clinical Trial Phase	Trials
Phase 4	6
Phase 3	51
Phase 2/Phase 3	6

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Taxotere
Clinical Trial Phase	Trials
Completed	197
Terminated	41
Unknown status	36

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Taxotere

Sponsor Name

Sponsor Name for Taxotere
Sponsor	Trials
Sanofi	55
National Cancer Institute (NCI)	51
Aventis Pharmaceuticals	24

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Taxotere
Sponsor	Trials
Other	325
Industry	226
NIH	51

Export unavailable in trial.
Subscribe for complete access.